Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Legal
Sort By
Newest First
1 / 1
1 / 1
Settlement
The Scripps Research Institute to Pay $10 Million to Settle False Claims Act Allegations Related to Mischarging NIH-Sponsored Research Grants
Scripps Research
PR-M09-20-25-1282
Sep 22, 2020
Legality
Legal Issues in Licensing and M&A
Randy Sunberg
Baker McKenzie
PAP-Q1-20-CL-028
Mar 19, 2020
Legal Settlement
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission
Mylan
PR-M09-19-NI-060
Sep 30, 2019
Movement in Cases Against Pharma Regarding the Opioid Crisis
Nice Insight
PA2120
Sep 11, 2019
Novartis Stands Behind Zolgensma® (onasemnogene abeparvovec-xioi) for the Treatment of Children Less than 2 Years of Age with Spinal Muscular Atrophy
Novartis
PR-M08-19-NI-023
Aug 08, 2019
Opioids
Analysis of Government Data Reveals Main Players in Opioid Market
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-013
Aug 07, 2019
Legal
Celgene to pay Mylan $62 Million to Resolve Cancer Drug Antitrust Case
Nice Insight
PR-M08-19-NI-007
Aug 02, 2019
Opioid Crisis
J&J Awaits Judge’s Decision in Lawsuit Filed by Oklahoma Over the Opioid Crisis
Nice Insight
PAO-M07-19-NI-021
Jul 22, 2019
Announcement
Bayer Supervisory Board Takes Action to Address the Glyphosate Litigation and Welcomes the Appointment of Ken Feinberg as Mediator
Bayer
PR-M07-19-NI-009
Jul 05, 2019
Advertising
Drug Companies Fight Back on TV Ad Pricing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M06-19-NI-019
Jun 21, 2019
Drug Pricing
Drug Affordability Review Board Created in Maryland
Nice Insight
PAO-M06-19-NI-007
Jun 13, 2019
Opioid Crisis
Oklahoma vs. Johnson & Johnson Opioid Crisis Trial
Nice Insight
PAO-M06-19-NI-006
Jun 13, 2019
Generics
State Lawsuit Charges Generic Makers with Price Fixing
Nice Insight
PAO-M05-19-NI-032
May 29, 2019
Legal
AbbVie Resolves HUMIRA® (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim
AbbVie
PR-M05-19-NI-056
May 20, 2019
Legal
U.S. Court of Appeals Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit
Eli Lilly and Company
PR-M04-19-NI-089
Apr 30, 2019
Legal
Novartis Goes to Court Over Gilenya Generics
Nice Insight
PAO-M07-18-NI-020
Jul 24, 2018
